Scientists focus on how T cells fight coronovirus in the absence of antibodies

Scientists focus on how T cells fight coronovirus in the absence of antibodies

Let’s Start this Interesting Article Shared on

As scientists question whether the presence, or absence, of antibodies to novel coronaviruses can reliably determine immunity, some are looking at a different component of the immune system, known as T cells, that is epidemic. For his role in protecting people.
Recent studies suggest that some patients who tested negative for coronovirus antibodies developed T cells in response to their Kovid-19 infection. While the studies are small and yet to be reviewed by outside experts, some scientists now say that people who experience a mild disease, or have no symptoms at all, from the new coronavirus, through this T cell response May end the infection.
The findings are linked to that an effective Kovid-19 vaccine must signal T cells to function in addition to producing antibodies, and may have implications for many treatments in development. They can also shed light on how immunity can work for new risk of infection.
“There is strong evidence that people exposed to the virus have a transient (short-term) antibody response, or a T cell response despite a minor or absent antibody response,” Dr. Alessandro Sette, professor and member of La Jolla told Reuters, the Institute’s Infectious Disease and Vaccine Center in California.
When a virus moves away from the body’s early activity – including infection-fighting white blood cells – a more specific “adaptive” response kicks in, triggering production of cells that target the invader. These include antibodies that can detect and lock on a virus, preventing entry into a person’s cells, as well as T cells that can kill both invaders and the cells they infect.
Six months into the global Kovid-19 pandemic that has infected more than 12 million people, questions remain as to whether the antibody response to this virus is strong and persists over time. This may mean that T cells have an important role in providing protection against disease.
“T cells are often important in controlling viral infections. We are seeing evidence of this,” John Wheeree, director of the University of Pennsylvania’s Institute for Immunology, told Reuters.
A recent small French study, which has not yet been reviewed by experts, found that six members of eight families developed a T cell response, but positive for antibodies, in contact with relatives with Kovid-19 Not tested
A Swedish study of 200 people found a strong T cell response in most individuals who had mild disease or no symptoms after coronovirus infection, even if they showed an antibody response. Researchers said this suggests that the rate of coronovirus infection may be higher than using antibody tests alone.
Attention to T cell responses may also shed light on the possibility for long-term immunity.
There is some evidence that T cells evolved after exposure to other coronaviruses, which can cause the common cold, which can help fight the new virus, known as SARS-CoV-2.
A study led by the La Jolla Institute detected T cells reacting to SARS-COV-2 in approximately half of the collected blood samples between 2015 and 2018, suggesting that the spread of the common cold coronaryus Immune system cells that have developed after a previous infection with, and they can help protect against new viruses.
“This is a potentially encouraging evidence,” Wherry said.
Vaccine candidates against Kovid-19 currently in the works are intended to generate antibody and T cell responses, and recent findings highlight the importance of observing the T cell response observed in human clinical trials.
“We believe that the optimal vaccine design will be one that induces both an antibody and a T cell response,” Sette said.
After an infection or vaccination, the immune system retains several “memory” cells that are already primed to attack the same virus quickly in case of future infection.
Many countries are using blood tests that use antibodies to estimate how many people have been infected with the new virus, even if they have never shown symptoms. But scientists still do not know how correlated antibody levels are with exposure to the virus or how long they may live. There are also questions about whether the combination of cells of the immune system will result in significant protection.
Measuring memory T levels is more complex, especially if cells are in lymph nodes or other hard-to-access areas of the body. In addition, T-cell responses are highly variable.
Assistant Professor at La Jolla Institute, Dr. “Antibody data is very easy to collect,” said Daniela Viskoff.


Leave a Reply

Your email address will not be published. Required fields are marked *